{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:57:47Z","timestamp":1790791067442,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271695"],"award-info":[{"award-number":["81271695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471774"],"award-info":[{"award-number":["81471774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007055","name":"Research Foundation of Third Military Medical University","doi-asserted-by":"publisher","award":["2014XJY04"],"award-info":[{"award-number":["2014XJY04"]}],"id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004602","name":"Program for New Century Excellent Talents in University","doi-asserted-by":"publisher","award":["NCET-13-0703"],"award-info":[{"award-number":["NCET-13-0703"]}],"id":[{"id":"10.13039\/501100004602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.biomaterials.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T02:30:14Z","timestamp":1470623414000},"page":"206-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"special_numbering":"C","title":["A superoxide dismutase\/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease"],"prefix":"10.1016","volume":"105","author":[{"given":"Qixiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2016.08.010_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2009.218","article-title":"Future biologic targets for IBD: potentials and pitfalls","volume":"7","author":"Melmed","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.1.5171.464","article-title":"Systemic and local corticosteroid therapy in ulcerative colitis","volume":"1","author":"Truelove","year":"1960","journal-title":"Br. Med. J."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11894-008-0089-5","article-title":"Adverse effects of nonsteroidal anti-inflammatory drugs on the colon","volume":"10","author":"Ballinger","year":"2008","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2009.06.061","article-title":"Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab","volume":"137","author":"Sandborn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nchembio.85","article-title":"Reconciling the chemistry and biology of reactive oxygen species","volume":"4","author":"Winterbourn","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biomaterials.2014.11.016","article-title":"ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease","volume":"41","author":"Poole","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.34.7.865","article-title":"Inflammatory bowel disease-a radical view","volume":"34","author":"Simmonds","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(94)92831-2","article-title":"Oxidants and free radicals in inflammatory bowel disease","volume":"344","author":"Grisham","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2741\/e463","article-title":"Oxidative stress and inflammatory bowel disease","volume":"4","author":"Almenier","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00054725-199712000-00003","article-title":"The role of reactive oxygen metabolites in ulcerative colitis","volume":"3","author":"Dagli","year":"1997","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0016-5085(92)91112-H","article-title":"Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease","volume":"103","author":"Simmonds","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/gut.34.9.1191","article-title":"Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis","volume":"34","author":"Sedghi","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0891-5849(92)90079-V","article-title":"Oxygen radicals in ulcerative colitis","volume":"13","author":"Babbs","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1189\/jlb.0304196","article-title":"Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine","volume":"76","author":"Segui","year":"2004","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib20","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1093\/carcin\/bgn211","article-title":"American ginseng suppresses inflammation and DNA damage associated with mouse colitis","volume":"29","author":"Jin","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrgastro.2010.66","article-title":"IBD: selective nanoparticle adhesion can enhance colitis therapy","volume":"7","author":"Lamprecht","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1226338","article-title":"Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities","volume":"338","author":"Cheng","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib23","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.addr.2004.08.011","article-title":"New oral delivery systems for treatment of inflammatory bowel disease","volume":"57","author":"Friend","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1517\/17425247.2012.730517","article-title":"Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease","volume":"9","author":"Xiao","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib26","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.biomaterials.2010.09.062","article-title":"Functional TNFalpha gene silencing mediated by polyethyleneimine\/TNFalpha siRNA nanocomplexes in inflamed colon","volume":"32","author":"Laroui","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.biomaterials.2010.09.034","article-title":"Oral nuclear factor-kappaB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease","volume":"32","author":"Tahara","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/j.gastro.2009.11.003","article-title":"Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model","volume":"138","author":"Laroui","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.gastro.2012.06.043","article-title":"An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice","volume":"143","author":"Vong","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2015.05.275","article-title":"Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy","volume":"210","author":"Vong","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2015.03.037","article-title":"Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer","volume":"55","author":"Vong","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib34","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1016\/j.biomaterials.2013.06.008","article-title":"Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-alpha RNA interference for IBD therapy","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2014.05.046","article-title":"Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis","volume":"188","author":"Moulari","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2015.37","article-title":"Nanomedicines in gastroenterology and hepatology","volume":"12","author":"Lamprecht","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib38","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.biomaterials.2008.08.009","article-title":"The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis","volume":"29","author":"Moulari","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/adhm.201400299","article-title":"Biocompatible reactive oxygen species (ROS)-responsive nanoparticles as superior drug delivery vehicles","volume":"4","author":"Zhang","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.7101","article-title":"ROS-responsive activatable photosensitizing agent for imaging and photodynamic therapy of activated macrophages","volume":"4","author":"Kim","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.intimp.2015.08.032","article-title":"IL-33 alleviates DSS-induced chronic colitis in C57BL\/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response","volume":"29","author":"Zhu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2007.11.004","article-title":"A\u00a0critical role of CD30 ligand\/CD30 in controlling inflammatory bowel diseases in mice","volume":"134","author":"Sun","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib45","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/ja110468v","article-title":"A\u00a0biocompatible oxidation-triggered carrier polymer with potential in therapeutics","volume":"133","author":"Broaders","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib46","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1002\/anie.201003819","article-title":"Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach","volume":"49","author":"Major Jourden","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib47","first-page":"137","article-title":"Susceptibility to hydrolysis of phenylboronic pinacol esters at physiological pH","volume":"11","author":"Achilli","year":"2013","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib48","first-page":"718617","article-title":"Dextran sodium sulphate colitis mouse model: traps and tricks","volume":"2012","author":"Perse","year":"2012","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib49","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00018-012-0963-z","article-title":"Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98","volume":"69","author":"Nguyen","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib50","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nrd1576","article-title":"Cyclodextrin-based pharmaceutics: past, present and future","volume":"3","author":"Davis","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib51","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.arcmed.2007.02.003","article-title":"New diseases derived or associated with the tight junction","volume":"38","author":"Cereijido","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1538\/expanim.48.137","article-title":"Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium","volume":"48","author":"Kitajima","year":"1999","journal-title":"Exp. Anim."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/gut.35.3.353","article-title":"Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis","volume":"35","author":"Pullan","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/gast.1996.v110.pm8608882","article-title":"Inflammatory bowel disease is associated with increased mucosal levels of bactericidal\/permeability-increasing protein","volume":"110","author":"Monajemi","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2016.08.010_bib56","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib57","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1073\/pnas.1424684112","article-title":"Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates","volume":"112","author":"Chou","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib58","doi-asserted-by":"crossref","first-page":"054101","DOI":"10.1088\/1748-6041\/5\/5\/054101","article-title":"Control of cell function on a phospholipid polymer having phenylboronic acid moiety","volume":"5","author":"Saito","year":"2010","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/mt.2013.214","article-title":"Targeting intestinal inflammation with CD98 siRNA\/PEI-loaded nanoparticles","volume":"22","author":"Laroui","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/labinvest.3700289","article-title":"Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation","volume":"85","author":"Kucharzik","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/10715769709097819","article-title":"Pharmacokinetic analysis of free radicals by in\u00a0vivo BCM (Blood Circulation Monitoring)-ESR method","volume":"26","author":"Takechi","year":"1997","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.biomaterials.2016.08.010_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2014.04.046","article-title":"Fab'-bearing siRNA TNFalpha-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis","volume":"186","author":"Laroui","year":"2014","journal-title":"J.\u00a0Control. Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216303969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216303969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:20:16Z","timestamp":1758903616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961216303969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":62,"alternative-id":["S0142961216303969"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.08.010","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A superoxide dismutase\/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}